openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizie

News

Discover

Markets

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizie

pembrolizumab — news, coverage & facts — IJR

|NewsJournalsTopicpembrolizumab

Topic

pembrolizumab

0 members

Feed News Media Community Answers Map About

1 mentions · 24hcoverage spread: L28/C47/R25

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Photo: Fletcher / Wikimedia Commons (CC BY 4.0)
Health
Merck, Moderna Positive Phase 3 Melanoma Vaccine
Merck and Moderna reported positive Phase 3 results for their personalized mRNA cancer vaccine intismeran autogene (V940/mRNA-4157) added to Keytruda in high-risk, surgically treated melanoma, showing longer recurrence-free survival and reduced distant metastasis with no new safety issues. The companies plan regulatory discussions and potential accelerated approval submissions, with data presentations at upcoming medical meetings and continued follow-up for overall survival.
245 sources

Facts from Wikidata (CC0).

Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. It is given by slow injection into a vein.

Read the full article →